XBiotech, Inc. Stock price
Is XBiotech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
XBiotech, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a XBiotech, Inc. forecast:
Analyst Opinions
7 Analysts have issued a XBiotech, Inc. forecast:
Don't miss a Thing! We will send you all news about XBiotech, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
XBiotech, Inc. Stock News
Company Profile
XBiotech, Inc. is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
| Head office | Canada |
| CEO | Dr. Shivaswamy |
| Employees | 87 |
| Founded | 2005 |
| Website | www.xbiotech.com |


